1.Research progress on interactions between medicinal plants and microorganisms.
Er-Jun WANG ; Ya-Long ZHANG ; Xiao-Hui MA ; Hua-Qian GONG ; Shao-Yang XI ; Gao-Sen ZHANG ; Ling JIN
China Journal of Chinese Materia Medica 2025;50(12):3267-3280
The interactions between microorganisms and medicinal plants are crucial to the quality improvement of medicinal plants. Medicinal plants attract microorganisms to colonize by secreting specific compounds and provide niche and nutrient support for these microorganisms, with a symbiotic network formed. These microorganisms grow in the rhizosphere, phyllosphere, and endophytic tissues of plants and significantly improve the growth performance and medicinal component accumulation of medicinal plants by promoting nutrient uptake, enhancing disease resistance, and regulating the synthesis of secondary metabolites. Microorganisms are also widely used in the ecological planting of medicinal plants, and the growth conditions of medicinal plants are optimized by simulating the microbial effects in the natural environment. The interactions between microorganisms and medicinal plants not only significantly improve the yield and quality of medicinal plants but also enhance their geoherbalism, which is in line with the concept of green agriculture and eco-friendly development. This study reviewed the research results on the interactions between medicinal plants and microorganisms in recent years and focused on the analysis of the great potential of microorganisms in optimizing the growth environment of medicinal plants, regulating the accumulation of secondary metabolites, inducing systemic resistance, and promoting the ecological planting of medicinal plants. It provides a scientific basis for the research on the interactions between medicinal plants and microorganisms, the research and development of microbial agents, and the application of microorganisms in the ecological planting of medicinal plants and is of great significance for the quality improvement of medicinal plants and the green and sustainable development of TCM resources.
Plants, Medicinal/metabolism*
;
Bacteria/genetics*
;
Symbiosis
2.Lirispirolides A-L, a new class of sesquiterpene-monoterpene heterodimers with anti-neuroinflammatory activity from the rare medicinal plant Liriodendron chinense.
Yuhang HE ; Kexin LI ; Yufei WU ; Zexin JIN ; Jinfeng HU ; Yicheng MAO ; Juan XIONG
Chinese Journal of Natural Medicines (English Ed.) 2025;23(8):938-950
Lirispirolides A-L (1-12), twelve novel sesquiterpene-monoterpene heterodimers featuring distinctive carbon skeletons, were isolated from the branches and leaves of Chinese tulip tree [Liriodendron chinense (L. chinense)], a rare medicinal and ornamental plant endemic to China. The structural elucidation was accomplished through comprehensive spectroscopic analyses, quantum-chemical calculations, and X-ray crystallography. These heterodimers exhibit a characteristic 2-oxaspiro[4.5]decan-1-one structural motif, biosynthetically formed through intermolecular [4 + 2]-cycloaddition between a germacrane-type sesquiterpene and an ocimene-type monoterpene. The majority of the isolated compounds demonstrated significant anti-neuroinflammatory effects in lipopolysaccharide (LPS)-induced BV-2 microglial cells by reducing the production of pro-inflammatory mediators, specifically tumor necrosis factor-α (TNF-α) and nitric oxide (NO). Further investigation revealed that the lirispirolides' inhibition of NO release correlated with decreased messenger ribonucleic acid (mRNA) expression of inducible NO synthase (iNOS).
Sesquiterpenes/isolation & purification*
;
Anti-Inflammatory Agents/isolation & purification*
;
Animals
;
Mice
;
Tumor Necrosis Factor-alpha/genetics*
;
Nitric Oxide/immunology*
;
Microglia/immunology*
;
Molecular Structure
;
Liriodendron/chemistry*
;
Monoterpenes/isolation & purification*
;
Plants, Medicinal/chemistry*
;
Cell Line
;
Lipopolysaccharides
;
Nitric Oxide Synthase Type II/immunology*
;
Plant Extracts/pharmacology*
;
China
3.Cultivation history and cultivars of medicinal Paeonia lactiflora in China.
Zhen-Yu ZHANG ; Shan-Shan CHU ; Hua-Sheng PENG
China Journal of Chinese Materia Medica 2024;49(22):6241-6248
Paeoniae Radix Alba, a commonly used traditional Chinese medicine derived from the dried roots of Paeonia lactiflora, is mainly produced in Anhui, Zhejiang, Sichuan, Shandong, and Hunan provinces. Since this plant has been cultivated for a long period, various cultivars have been formed in different producing areas. Based on systematic herbal textual research and a review of local chronicles, this study investigated the germplasm resources of medicinal P. lactiflora in the five main producing areas of Paeoniae Radix Alba. Furthermore, it outlined the cultivation history and current status of the germplasm resources of medicinal P. lactiflora in these regions. The results indicated that among the 12 medicinal cultivars of P. lactiflora, 8 cultivars were monopetalous red flowers, which are consistent with the medicinal germplasm highly regarded throughout history in ancient medical books. Additionally, there are cultivars with monopetalous white flowers, polypetalous white flowers, and polypetalous pink flowers in the main producing areas, indicating the rich germplasm resources of medicinal P. lactiflora in China. This paper provides a survey basis for the germplasm conservation and rational resource utilization of high-quality medicinal P. lactiflora.
Paeonia/genetics*
;
China
;
Plants, Medicinal/genetics*
;
History, 20th Century
;
History, Ancient
;
History, 21st Century
;
History, 19th Century
;
Drugs, Chinese Herbal
;
Flowers/growth & development*
;
History, 17th Century
;
History, 18th Century
4.Establishment of a standard DSS library for identification of original plants of medicinal materials in Chinese Pharmacopoeia.
Duo-Mei WANG ; Chao JIANG ; Jing-Zhe PU ; Chong HU ; Ling-Li CHEN ; Ya-Zhong ZHANG ; Yuan YUAN
China Journal of Chinese Materia Medica 2024;49(23):6249-6256
With the development of molecular pharmacognosy, the advantages of DNA molecular markers in the identification of original plants of Chinese medicinal materials are becoming increasingly significant. To compensate for the limitations of existing markers in the quality supervision of Chinese medicinal materials, our team has independently designed a new molecular marker named DNA signature sequence(DSS). This marker is a nucleotide sequence that only appears in a specific taxonomic unit, with a length of 40 bp and high identification accuracy. This article aims to screen and verify the DSS markers that can accurately identify the original plants of the medicinal materials included in the volume one of the Chinese Pharmacopoeia, establish the operating procedure for developing standard nucleotide sequences, and lay a foundation for the widespread application of polymerase chain reaction in the quality supervision of traditional Chinese medicine. Firstly, the Chloroplast Genome Information Resource(CGIR) was searched for the chloroplast genome sequences of the test samples, species of the same genus, and common background species. IdenDSS was used to obtain the DSS tags and specific identification primers of the tested species. After DNA extraction, PCR amplification, sequencing, and sequence alignments, a total of 203 DSS markers of Chinese medicinal materials were obtained for validation. The above sequences were uploaded to the Traditional Chinese Medicine Molecular Identification Platform(www.herbsdna.com), and a standard DSS library was established for identifying the original plants of medicinal materials, serving as an important tool for quality supervision of Chinese materia medica. On this basis, an operating procedure for DSS development is formed, laying a foundation for further DSS screening and application based on more diverse genome sequences.
Plants, Medicinal/classification*
;
DNA, Plant/genetics*
;
Drugs, Chinese Herbal
;
Pharmacopoeias as Topic
;
Genetic Markers
;
Medicine, Chinese Traditional
5.Application of tissue culture technology of medicinal plants in sustainable development of Chinese medicinal resources.
Cheng-Cai ZHANG ; Sheng WANG ; Yue-Feng WANG ; Hong-Yang WANG ; Ming QIN ; Xiao-Yu DAI ; Bin-Bin YAN ; Xiu-Zhi GUO ; Li ZHOU ; Huai-Bin LIN ; Lan-Ping GUO
China Journal of Chinese Materia Medica 2023;48(5):1186-1193
Chinese medicinal resources are the cornerstone of the sustainable development of traditional Chinese medicine industry. However, due to the fecundity of species, over-exploitation, and limitations of artificial cultivation, some medicinal plants are depleted and even endangered. Tissue culture, a breakthrough technology in the breeding of traditional Chinese medicinal materials, is not limited by time and space, and can allow the production on an annual basis, which plays an important role in the protection of Chinese medicinal resources. The present study reviewed the applications of tissue culture of medicinal plants in the field of Chinese medicinal resources, including rapid propagation of medicinal plant seedlings, breeding of novel high-yield and high-quality cultivars, construction of a genetic transformation system, and production of secondary metabolites. Meanwhile, the current challenges and suggestions for the future development of this field were also proposed.
Sustainable Development
;
Plants, Medicinal/genetics*
;
Plant Breeding
;
Medicine, Chinese Traditional
;
Technology
6.Comprehensive evaluation of Pinellia ternata germplasm resources based on phenotypic trait classification.
Li LIU ; Xue FENG ; Jia-Lu WANG ; Jia-Lei CHEN ; Meng-Meng HOU ; Xiang-Yu ZHANG ; Kai-Yang LI ; Xi-Wen LI ; Shi-Lin CHEN
China Journal of Chinese Materia Medica 2023;48(24):6613-6623
The evaluation of germplasm resources is the prerequisite for the development, utilization, and conservation of Chinese medicinal resources. The selection of excellent germplasm is the key to the breeding and orderly production of Pinellia ternata. In this study, 21 germplasm materials of P. ternata from major production areas in China were collected and analyzed for population diversity after phenotypic preliminary screening. The results have revealed that the P. ternata population has abundant phenotypic variation, and the phenotypic changes could be divided into five phenotypes in terms of organ trait variation. Further analysis of variation in 20 quantitative traits of the population revealed that the coefficient of variation for adenosine content(339.05%) was the largest, while the coefficient of variation for the underground plant height(16.35%) was the smallest. Correlation analysis showed that there was a strong correlation among various traits, with 52 pairs of traits showing highly significant correlation(P<0.01) and 19 pairs of traits showing a significant correlation(P<0.05). The 21 germplasms in the test could be classified into three major clusters by cluster analysis, with Cluster Ⅱ having the highest number and content of nucleosides, making it suitable for the selection and breeding of P. ternata varieties with high content of nucleosides. The yield in Cluster Ⅲ was higher than that in other groups, making it suitable for the selection and breeding of P. ternata varieties with a high yield. All trait indicators could be simplified into five principal component factors through principal component analysis, and the cumulative contribution rate was up to 86.04%. Further, comprehensive analysis using membership function and stepwise regression analysis identified nine traits, such as plant height, main leaf length, and underground plant height as characteristic indicators for the comprehensive evaluation of germplasm resources of P. ternata. BX007, BX008, and BX005 were identified as germplasms with both high yield and high uridine content, with BX007 having the highest uridine content of 479.51 μg·g~(-1). It belonged to the germplasm of P. ternata with double bulbils and could be cultivated as a potential good variety. Based on the phenotypic classification of P. ternata, systematic resource evaluation was carried out in this study, which could lay a foundation for the excavation of genetic resources and the breeding of new varieties of P. ternata.
Plants, Medicinal
;
Pinellia/genetics*
;
Plant Breeding
;
Phenotype
;
Uridine
7.DUS testing guidelines for new varieties of Chinese medicinal plants.
Cheng-Cai ZHANG ; Chao FANG ; Ming QIN ; Hong-Yang WANG ; Xiu-Zhi GUO ; Yue-Feng WANG ; Bin-Bin YAN ; Zi-Hua ZHANG ; Sheng WANG ; Lan-Ping GUO
China Journal of Chinese Materia Medica 2023;48(11):2896-2903
A rich diversity of wild medicinal plant resources is distributed in China, but the breeding of new plant varieties of Chinese medicinal plants started late and the breeding level is relatively weak. Chinese medicinal plant resources are the foundation for new varieties breeding, and the plant variety rights(PVP) are of great significance for the protection and development of germplasm resources. However, most Chinese medicinal plants do not have a distinctness, uniformity, and stability(DUS) testing guideline. The Ministry of Agriculture and Rural Affairs has put 191 plant species(genera) on protection lists, of which only 30 are medicinal species(genera). At the same time, only 29 of 293 species(genera) plants in the Protection List of New Plant Varieties of the People's Republic of China(Forest and Grass) belong to Chinese medicinal plants. The number of PVP applications and authorization of Chinese medicinal plants is rare, and the composition of variety is unreasonable. Up to now, 29 species(genera) of DUS test guidelines for Chinese medicinal plants have been developed. Some basic problems in the breeding of new varieties of Chinese medicinal plants have appeared, such as the small number of new varieties and insufficient utilization of Chinese medicinal plant resources. This paper reviewed the current situation of breeding of new varieties of Chinese medicinal plants and the research progress of DUS test guidelines in China and discussed the application of biotechnology in the field of Chinese medicinal plant breeding and the existing problems in DUS testing. This paper guides the further application of DUS to protect and utilize the germplasm resources of Chinese medicinal plants.
Agriculture
;
Biotechnology
;
Plant Breeding
;
Plants, Medicinal/genetics*
8.Physiological and transcriptional responses to heat stress in a typical phenotype of Pinellia ternata.
Jialu WANG ; Jialei CHEN ; Xiangyu ZHANG ; Xue FENG ; Xiwen LI
Chinese Journal of Natural Medicines (English Ed.) 2023;21(4):243-252
Pinellia ternata is an important medicinal plant, and its growth and development are easily threatened by high temperature. In this study, comprehensive research on physiological, cytological and transcriptional responses to different levels of heat stress were conducted on a typical phenotype of P. ternata. First, P. ternata exhibited tolerance to the increased temperature, which was supported by normal growing leaves, as well as decreased and sustained photosynthetic parameters. Severe stress aggravated the damages, and P. ternata displayed an obvious leaf senescence phenotype, with significantly increased SOD and POD activities (46% and 213%). In addition, mesophyll cells were seriously damaged, chloroplast thylakoid was fuzzy, grana lamellae and stroma lamellae were obviously broken, and grana thylakoids were stacked, resulting in a dramatically declined photosynthetic rate (74.6%). Moreover, a total of 16 808 genes were significantly differential expressed during this process, most of which were involved in photosynthesis, transmembrane transporter activity and plastid metabolism. The number of differentially expressed transcription factors in MYB and bHLH families was the largest, indicating that these genes might participate in heat stress response in P. ternata. These findings provide insight into the response to high temperature and facilitate the standardized cultivation of P. ternata.
Pinellia/genetics*
;
Heat-Shock Response/genetics*
;
Photosynthesis/genetics*
;
Plants, Medicinal/genetics*
;
Phenotype
9.Mining Therapeutic Efficacy from Treasure Chest of Biodiversity and Chemodiversity: Pharmacophylogeny of Ranunculales Medicinal Plants.
Da-Cheng HAO ; Li-Jia XU ; Yu-Wei ZHENG ; Huai-Yu LYU ; Pei-Gen XIAO
Chinese journal of integrative medicine 2022;28(12):1111-1126
Ranunculales, comprising of 7 families that are rich in medicinal species frequently utilized by traditional medicine and ethnomedicine, represents a treasure chest of biodiversity and chemodiversity. The phylogenetically related species often have similar chemical profile, which makes them often possess similar therapeutic spectrum. This has been validated by both ethnomedicinal experiences and pharmacological investigations. This paper summarizes molecular phylogeny, chemical constituents, and therapeutic applications of Ranunculales, i.e., a pharmacophylogeny study of this representative medicinal order. The phytochemistry/metabolome, ethnomedicine and bioactivity/pharmacology data are incorporated within the phylogenetic framework of Ranunculales. The most studied compounds of this order include benzylisoquinoline alkaloid, flavonoid, terpenoid, saponin and lignan, etc. Bisbenzylisoquinoline alkaloids are especially abundant in Berberidaceae and Menispermaceae. The most frequent ethnomedicinal uses are arthritis, heat-clearing and detoxification, carbuncle-abscess and sore-toxin. The most studied bioactivities are anticancer/cytotoxic, antimicrobial, and anti-inflammatory activities, etc. The pharmacophylogeny analysis, integrated with both traditional and modern medicinal uses, agrees with the molecular phylogeny based on chloroplast and nuclear DNA sequences, in which Ranunculales is divided into Ranunculaceae, Berberidaceae, Menispermaceae, Lardizabalaceae, Circaeasteraceae, Papaveraceae, and Eupteleaceae families. Chemical constituents and therapeutic efficacy of each taxonomic group are reviewed and the underlying connection between phylogeny, chemodiversity and clinical uses is revealed, which facilitate the conservation and sustainable utilization of Ranunculales pharmaceutical resources, as well as developing novel plant-based pharmacotherapy.
Humans
;
Plants, Medicinal/chemistry*
;
Phylogeny
;
Ranunculaceae/genetics*
;
Medicine, Traditional
;
Alkaloids
;
Biodiversity
;
Benzylisoquinolines
10.Chloroplast genome structure characteristics and phylogenetic analysis of Artemisia indica.
Zhao-Hui LAN ; Xu-Fang TIAN ; Yu-Hua SHI ; Ran-Ran GAO ; Qing-Gang YIN ; Li XIANG ; Lan WU
China Journal of Chinese Materia Medica 2022;47(22):6058-6065
Artemisia indica is an important medicinal plant in the Asteraceae family, but its molecular genetic information has been rarely reported. In this study, the chloroplast genome of A. indica was sequenced, assembled, and annotated by the high-throughput sequencing technology, and its sequence characteristics, repeat sequences, codon usage bias, and phylogeny were analyzed. The results showed that the length of the chloroplast genome for A. indica was 151 161 bp, which was a typical circular four-segment structure, including two inverted repeat regions(IRs), a large single-copy(LSC) region, and a small single-copy(SSC) region, with a GC content of 37.47%. A total of 132 genes were annotated, and 114 were obtained after de-duplication, including 80 protein-coding genes, 30 tRNA genes, and 4 rRNA genes. Fifty long repeat sequences and 191 SSRs were detected in the chloroplast genome of A. indica, and SSRs were mainly single nucleotides. Codon usage bias analysis showed that leucine was the most frequently used amino acid(10.77%) in the chloroplast genome, and there were 30 codons with relative synonymous codon usage(RSCU)>1 and all ended with A/U. The phylogenetic tree constructed based on the chloroplast genomes of the 19 species from the Asteraceae family showed that A. indica and A. argyi were closest in the genetic relationship, and Artemisia species clustered into separate evolutionary branches. The results of this study are expected to provide a theoretical basis for the genetic diversity and resource conservation of Artemisia medicinal plants.
Genome, Chloroplast
;
Phylogeny
;
Artemisia/genetics*
;
Codon/genetics*
;
Base Composition
;
Plants, Medicinal/genetics*

Result Analysis
Print
Save
E-mail